Protein Slows Cancer with Cell Cycle Interference

Many miRNAs are conserved in sequence between distantly related organisms, suggesting that these molecules participate in essential processes. In fact, miRNAs have been shown to be involved in the regulation of gene expression during development, cell proliferation, apoptosis, glucose metabolism, stress resistance, and cancer.

Investigators at the University of Rochester Medical Center (NY, USA) furthered the understanding of miRNA decay when they identified the enzyme Tudor-SN, an endonuclease that interacted with the RNA-induced silencing complex. Tudor-SN was found to target miRNAs at CA (cytosine- adenine) and UA (uracil-adenine) dinucleotides located more than five nucleotides from miRNA ends. Tudor-SN-mediated miRNA decay removed miRNAs that silenced genes encoding proteins that were critical for the G1-to-S phase transition in the cell cycle.

The investigators reported in the May 26, 2017, issue of the journal Science that inhibiting TSN-mediated miRNA decay by CRISPR-Cas9 knockout of TSN slowed cell cycle progression by up-regulating a cohort of miRNAs that interfered with the mRNAs that encoded proteins critical for the G1-to-S phase transition. Thus, removal of Tudor-SN from human cells increased the levels of dozens of microRNAs. This increase in the number of inhibitory molecules resulted in the shutdown of genes that encouraged cell growth by regulating the cell cycle.

"We know that Tudor-SN is more abundant in cancer cells than healthy cells, and our study suggests that targeting this protein could inhibit fast-growing cancer cells," said first author Dr. Reyad A. Elbarbary, research assistant professor of biochemistry and biophysics at the University of Rochester School of Medical Center.

Related Links
University of Rochester Medical Center